Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Jazz Pharma To FDA: What Patient Deaths?
Pharmalot
Tuesday, October 18, 2011 - 12:16pm
tags:
FDA, death, Jazz Pharmaceuticals, Xyrem
Bristol-Myers, Sanofi $442 Million Plavix Award Upheld on Appeal
Bloomberg
Tuesday, October 18, 2011 - 12:13pm
tags:
Plavix, Sanofi, Bristol-Myers Squibb, patents
GlaxoSmithKline to Make a Bid for Human Genome Sciences?
Yahoo/Wall St. Cheat Sheet
Tuesday, October 18, 2011 - 12:12pm
tags:
GSK, Human Genome Sciences, M&A
Par acquires three generics from Teva
Drugstore News
Tuesday, October 18, 2011 - 10:40am
tags:
Teva Pharmaceuticals, generics, Par Pharmaceutical, Actiq, Provigil, Amrix
6 Biotech Stocks With A History Of Earnings Surprises
Seeking Alpha
Tuesday, October 18, 2011 - 10:36am
tags:
Array Biopharma, earnings, Aveo Pharmaceutical, Cornerstone Therapeutics, Neuralstem, Immunogen, Jazz Pharmaceuticals
Halozyme rallies on Herceptin drug study
Marketwatch
Tuesday, October 18, 2011 - 10:34am
tags:
Halozyme, Herceptin, Roche, breast cancer
Forest Labs Posts Weak Quarter
TheStreet.com
Tuesday, October 18, 2011 - 10:33am
tags:
earnings, Forest Labs
FDA Panel: Teva Parkinson's Drug Doesn't Slow Disease
NASDAQ.com
Tuesday, October 18, 2011 - 9:26am
tags:
FDA, advisory panels, Teva Pharmaceuticals, Parkinson's Disease, Azilect
Embryonic Stem-Cell Patents Infringe EU Law, Top Court Says
Bloomberg
Tuesday, October 18, 2011 - 9:24am
tags:
embryonic stem cells, Europe, stem cells
Third Rock Ventures launches new biotech, SAGE Therapeutics
Bizjournals.com
Tuesday, October 18, 2011 - 9:23am
tags:
SAGE Therapeutics, Third Rock, CNS
5 Top Birth Control Stocks To Hold As Contraception Skyrockets Due to Recession
Seeking Alpha
Tuesday, October 18, 2011 - 9:01am
tags:
contraceptives, birth control, JNJ, Merck, Pfizer, Teva Pharmaceuticals
J&J Third-Quarter Profit Declines on Generics
Bloomberg
Tuesday, October 18, 2011 - 9:00am
tags:
earnings, generics, JNJ
Astra, Forest to start Phase 3 superbug drug study
Reuters
Tuesday, October 18, 2011 - 8:59am
tags:
AstraZeneca, Forest Labs, CAZ-AVI, antibiotics, superbugs
Anadys acquisition sign of more to come
The Deal
Tuesday, October 18, 2011 - 8:53am
tags:
Anadys, Roche, Merck, JNJ, Achillion, M&A, Indenix, Bristol-Myers Squibb
The 8 Highest Potential Returns in Biotechnology
Motley Fool
Monday, October 17, 2011 - 7:33pm
tags:
Biomarin, Emergent BioSolutions, United Therapeutics, Gilead, 3SBio, Targacept, Amgen, Celgene
Earnings Preview: Abbott to report 3Q earnings
Yahoo/AP
Monday, October 17, 2011 - 7:31pm
tags:
Abbott Laboratories, earnings
Par Pharma sues FDA, claiming free speech rights
Fierce Pharma
Monday, October 17, 2011 - 7:31pm
tags:
FDA, lawsuits, free speech, Par Pharmaceutical, off-label, Allergan
Roche's All-Oral Hep C Therapy Could Be First, Not Best, to Reach Market
TheStreet.com
Monday, October 17, 2011 - 1:22pm
tags:
Roche, M&A, Anadys, hepatitis C, Pegasys, setrobuvir, Merck, Victrelis, RG7128, Pharmasset
Infinity advances pancreatic cancer drug candidate
Bizjournals.com
Monday, October 17, 2011 - 1:20pm
tags:
Infinity, pancreatic cancer, IPI-926
With Earnings Around The Corner, Human Genome Continues To Drop
Seeking Alpha
Monday, October 17, 2011 - 12:09pm
tags:
earnings, Human Genome Sciences

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.